CD4 and neoplasm: In a lung cancer model with high expression of the chemokine ligand 9 (CXCL9), CXCL11, and granzyme B, cryptotanshinone was shown to increase the infiltration of CD8+ T and CD4+ T cells in the TME to enhance the anti-tumor effect of PD-1 blockade therapy [215].